Back to Search Start Over

Thiamine responsive megaloblastic anemia syndrome.

Authors :
Ganesh R
Ezhilarasi S
Vasanthi T
Gowrishankar K
Rajajee S
Source :
Indian journal of pediatrics [Indian J Pediatr] 2009 Mar; Vol. 76 (3), pp. 313-4. Date of Electronic Publication: 2009 Apr 06.
Publication Year :
2009

Abstract

Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness. We report a 4-year-old girl with TRMA whose anemia improved following administration of thiamine and this case report sensitizes the early diagnosis and treatment with thiamine in children presenting with anemia, diabetes and deafness.

Subjects

Subjects :
Anemia, Megaloblastic complications
Anemia, Megaloblastic diagnosis
Anemia, Megaloblastic genetics
Blood Glucose metabolism
Child, Preschool
Diabetes Mellitus, Type 1 complications
Diabetes Mellitus, Type 1 genetics
Female
Follow-Up Studies
Hearing Loss, Sensorineural complications
Hearing Loss, Sensorineural genetics
Humans
Syndrome
Anemia, Megaloblastic drug therapy
Thiamine therapeutic use

Details

Language :
English
ISSN :
0973-7693
Volume :
76
Issue :
3
Database :
MEDLINE
Journal :
Indian journal of pediatrics
Publication Type :
Academic Journal
Accession number :
19347672
Full Text :
https://doi.org/10.1007/s12098-009-0058-5
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details